ES2111031T3 - Uso de preparaciones que contienen anticuerpos para la inmunosupresion. - Google Patents
Uso de preparaciones que contienen anticuerpos para la inmunosupresion.Info
- Publication number
- ES2111031T3 ES2111031T3 ES92117775T ES92117775T ES2111031T3 ES 2111031 T3 ES2111031 T3 ES 2111031T3 ES 92117775 T ES92117775 T ES 92117775T ES 92117775 T ES92117775 T ES 92117775T ES 2111031 T3 ES2111031 T3 ES 2111031T3
- Authority
- ES
- Spain
- Prior art keywords
- immunosuppression
- preparations containing
- containing antibodies
- preparations
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Abstract
LA PRESENTE INVENCION SE REFIERE AL EMPLEO DE PREPARADOS QUE CONTIENEN ANTICUERPOS DIRIGIDOS CONTRA EL VCD44 PARA LA INMUNOSUPRESION.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4134982A DE4134982A1 (de) | 1991-10-23 | 1991-10-23 | Verwendung von antikoerper enthaltenden praeparationen zur immunsuppression |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2111031T3 true ES2111031T3 (es) | 1998-03-01 |
Family
ID=6443260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES92117775T Expired - Lifetime ES2111031T3 (es) | 1991-10-23 | 1992-10-17 | Uso de preparaciones que contienen anticuerpos para la inmunosupresion. |
Country Status (17)
Country | Link |
---|---|
US (1) | US5951982A (es) |
EP (1) | EP0538754B1 (es) |
JP (1) | JPH05310596A (es) |
KR (1) | KR100252620B1 (es) |
AT (1) | ATE162079T1 (es) |
AU (1) | AU659687B2 (es) |
CA (1) | CA2081150C (es) |
DE (2) | DE4134982A1 (es) |
DK (1) | DK0538754T3 (es) |
ES (1) | ES2111031T3 (es) |
GR (1) | GR3026526T3 (es) |
HU (1) | HU216020B (es) |
IL (1) | IL103510A0 (es) |
NO (1) | NO311965B1 (es) |
NZ (1) | NZ244851A (es) |
TW (1) | TW273514B (es) |
ZA (1) | ZA928162B (es) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5589458A (en) * | 1992-11-13 | 1996-12-31 | Thomas Jefferson University | Compounds that inhibit T cell proliferation and methods for using the same |
DE69406664T2 (de) * | 1993-06-18 | 1998-06-04 | Biotie Therapies Oy | Zusammensetzungen und diagnostische verfahren unter verwendung von monoklonalen antikoerpern gegen cd44v6 |
DE4326573A1 (de) * | 1993-08-07 | 1995-02-23 | Boehringer Ingelheim Int | Durch Exon v5 des CD44-Gens kodierte Polypeptide als Targets für Immuntherapie und Immunszintigraphie von Tumoren |
DE4431297A1 (de) * | 1994-09-02 | 1996-03-07 | Boehringer Ingelheim Int | Monoklonaler Antikörper gegen CD44v6 |
DE19540515C1 (de) * | 1995-10-31 | 1997-02-06 | Boehringer Ingelheim Int | Tumortherapie durch adoptiven Transfer CD44v-spezifischer zytotoxischer T-Lymphozyten |
EP0881299A4 (en) * | 1996-02-15 | 2004-12-15 | Chugai Seiyakukabushiki Kaisha | MONOCLONAL ANTIBODIES RECOGNIZING ANTIGENS PRESENT ON THE SURFACE OF ENDOTHELIAL CELLS OF A TUMOR VESSEL |
US6136311A (en) | 1996-05-06 | 2000-10-24 | Cornell Research Foundation, Inc. | Treatment and diagnosis of cancer |
DE19652815C2 (de) * | 1996-12-18 | 1999-11-11 | Karlsruhe Forschzent | Mittel zur Identifizierung und Therapie metastasierender Tumore |
DE19653607A1 (de) | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Int | Verfahren zur Diagnose und Therapie von Hodgkin-Lymphomen |
DE19708713C2 (de) * | 1997-03-04 | 2002-11-28 | Boehringer Ingelheim Int | Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen |
IL121656A0 (en) * | 1997-08-29 | 1998-02-08 | Yissum Res Dev Co | Diagnosis prevention and treatment of diabetes |
US7534605B2 (en) * | 1999-06-08 | 2009-05-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
AU2003272511A1 (en) * | 2002-09-13 | 2004-04-30 | Dyax Corporation | Cd44-binding ligands |
US9701754B1 (en) | 2002-10-23 | 2017-07-11 | City Of Hope | Covalent disulfide-linked diabodies and uses thereof |
CA2560200A1 (en) * | 2004-03-17 | 2005-09-22 | Academisch Ziekenhuis Bij De Universiteit Van Amsterdam | Cd44-targeting for reducing/preventing ischemia-reperfusion-injury |
EP1924606A4 (en) | 2005-08-25 | 2010-01-13 | Repair Technologies Inc | DEVICES, COMPOSITIONS AND METHODS FOR PROTECTING AND REPAIRING CELLS AND TISSUE |
EP1996716B1 (en) | 2006-03-20 | 2011-05-11 | The Regents of the University of California | Engineered anti-prostate stem cell antigen (psca) antibodies for cancer targeting |
JP6126773B2 (ja) | 2007-09-04 | 2017-05-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 癌のターゲッティングおよび検出のための高親和性抗前立腺幹細胞抗原(psca)抗体 |
WO2010058396A1 (en) | 2008-11-19 | 2010-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | A cd44vra antibody and diagnostic and therapeutic methods using same |
WO2010096486A1 (en) | 2009-02-17 | 2010-08-26 | Cornell Research Foundation, Inc. | Methods and kits for diagnosis of cancer and prediction of therapeutic value |
CA2782333C (en) | 2009-12-02 | 2019-06-04 | Imaginab, Inc. | J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
PL2886126T3 (pl) | 2013-12-23 | 2017-11-30 | Exchange Imaging Technologies Gmbh | Nanocząstka sprzężona z peptydami wiążącymi CD44 |
HUE049261T2 (hu) | 2014-07-15 | 2020-09-28 | Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd | CD44 izolált polipeptidek és alkalmazásaik |
NZ739721A (en) | 2015-08-07 | 2019-09-27 | Imaginab Inc | Antigen binding constructs to target molecules |
WO2018147960A1 (en) | 2017-02-08 | 2018-08-16 | Imaginab, Inc. | Extension sequences for diabodies |
US11313243B2 (en) | 2018-07-12 | 2022-04-26 | Rolls-Royce North American Technologies, Inc. | Non-continuous abradable coatings |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE114478T1 (de) * | 1987-08-11 | 1994-12-15 | Univ Leland Stanford Junior | Verfahren zur kontrolle der leukozyten- extravasation. |
DE4014510A1 (de) * | 1990-05-07 | 1991-11-14 | Kernforschungsz Karlsruhe | Variante cd44-oberflaechenproteine, diese kodierende c-dna-sequenzen, antikoerper gegen diese proteine sowie ihre verwendung in der diagnostik und therapie |
CA2059824A1 (en) * | 1991-02-26 | 1992-08-27 | Thomas M. Aune | Hybridomas and monoclonal antibodies that inhibit anti-cd3-stimulated t cell proliferation |
DE69406664T2 (de) * | 1993-06-18 | 1998-06-04 | Biotie Therapies Oy | Zusammensetzungen und diagnostische verfahren unter verwendung von monoklonalen antikoerpern gegen cd44v6 |
-
1991
- 1991-10-23 DE DE4134982A patent/DE4134982A1/de not_active Withdrawn
-
1992
- 1992-10-07 TW TW081107971A patent/TW273514B/zh active
- 1992-10-17 DK DK92117775.4T patent/DK0538754T3/da active
- 1992-10-17 EP EP92117775A patent/EP0538754B1/de not_active Expired - Lifetime
- 1992-10-17 AT AT92117775T patent/ATE162079T1/de not_active IP Right Cessation
- 1992-10-17 ES ES92117775T patent/ES2111031T3/es not_active Expired - Lifetime
- 1992-10-17 DE DE59209129T patent/DE59209129D1/de not_active Expired - Fee Related
- 1992-10-21 NZ NZ244851A patent/NZ244851A/en unknown
- 1992-10-22 ZA ZA928162A patent/ZA928162B/xx unknown
- 1992-10-22 KR KR1019920019468A patent/KR100252620B1/ko not_active IP Right Cessation
- 1992-10-22 AU AU27244/92A patent/AU659687B2/en not_active Ceased
- 1992-10-22 IL IL103510A patent/IL103510A0/xx unknown
- 1992-10-22 NO NO19924103A patent/NO311965B1/no not_active IP Right Cessation
- 1992-10-22 HU HUP9203337A patent/HU216020B/hu not_active IP Right Cessation
- 1992-10-22 CA CA002081150A patent/CA2081150C/en not_active Expired - Fee Related
- 1992-10-23 JP JP4307913A patent/JPH05310596A/ja active Pending
-
1994
- 1994-12-20 US US08/359,850 patent/US5951982A/en not_active Expired - Lifetime
-
1998
- 1998-04-03 GR GR980400710T patent/GR3026526T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0538754A2 (de) | 1993-04-28 |
NO924103D0 (no) | 1992-10-22 |
ATE162079T1 (de) | 1998-01-15 |
NO924103L (no) | 1993-04-26 |
CA2081150A1 (en) | 1993-04-24 |
IL103510A0 (en) | 1993-03-15 |
KR930007460A (ko) | 1993-05-20 |
JPH05310596A (ja) | 1993-11-22 |
AU2724492A (en) | 1993-04-29 |
DE59209129D1 (de) | 1998-02-19 |
CA2081150C (en) | 2001-04-10 |
GR3026526T3 (en) | 1998-07-31 |
DE4134982A1 (de) | 1993-04-29 |
US5951982A (en) | 1999-09-14 |
EP0538754A3 (en) | 1994-05-25 |
NO311965B1 (no) | 2002-02-25 |
HUT63063A (en) | 1993-07-28 |
EP0538754B1 (de) | 1998-01-14 |
NZ244851A (en) | 1997-07-27 |
TW273514B (es) | 1996-04-01 |
KR100252620B1 (ko) | 2000-09-01 |
HU216020B (hu) | 1999-04-28 |
ZA928162B (en) | 1993-05-05 |
AU659687B2 (en) | 1995-05-25 |
DK0538754T3 (da) | 1998-03-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2111031T3 (es) | Uso de preparaciones que contienen anticuerpos para la inmunosupresion. | |
FI931708A0 (fi) | Herbicida substituerade aryl-haloalkylpyrazoler | |
ATE193839T1 (de) | Reinigung von proteinen | |
NO864971L (no) | Fremgangsmaate for fremstilling av monoklonale antistoffer som er kryssbeskyttende overfor p. aeruginosaserotyper. | |
MX24890A (es) | Polipeptido sintetico, procedimiento par su preparacion y composicion farmaceutica que lo contiene. | |
EP0141143A3 (en) | Sebosuppressive cosmetic compositions containing benzyl alcohol derivatives | |
FI892222A0 (fi) | Peptidalkoholer med antikoagulantverkan. | |
NO923266L (no) | Heksahydrobenzo(f)quinolinoner | |
MX9302878A (es) | Procedimiento para la preparacion de un diaminodiol substituido. | |
DE58907569D1 (de) | Isomere Trimethylbicyclo[4.3.0]nonan-Derivate. | |
AU560165B2 (en) | Chromophoric peptides | |
NO903599L (no) | Minoxidilgel. | |
KR950009091B1 (en) | Antidepressants containing 1-benzyl-aminoalkyl-pyrrolidinones | |
ES1014032Y (es) | Estuche para la presentacion de muestras. | |
SE9203747D0 (sv) | Raettstaenger foer personbilar | |
IT1263170B (it) | Composizione antiemorroidale | |
ES1004160Y (es) | Polaina portadora de objetos de uso personal. | |
BR8706472A (pt) | Racionalizador para o uso de elevadores | |
MX9102492A (es) | Procedimiento para la determinacion del origen de bebidas espirituosas. | |
KR870015891U (ko) | 교자상 다리의 고정장치 | |
MX13776A (es) | Procedimiento para la preparacion de compuestos de subtituidos de tiazodilidindiona. | |
ES1022662Y (es) | Dispositivo para la utilizacion de bicicletas convencionales como bicicletas estaticas. | |
BR8606177A (pt) | Pecas acessorias para montagem de triciclo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 538754 Country of ref document: ES |